Strategies for Managing Suboptimal Response to JAK Inhibitors in Alopecia Areata
DOI:
https://doi.org/10.2340/actadv.v105.44193Keywords:
Alopecia areata, JAK inhibitors, clinical effectiveness, managementDownloads
References
Kwon O, Senna MM, Sinclair R, Ito T, Dutronc Y, Lin CY, et al. Efficacy and safety of baricitinib in patients with severe alopecia areata over 52 weeks of continuous therapy in two phase III trials (BRAVE-AA1 and BRAVE-AA2). Am J Clin Dermatol 2023; 24: 443–451. DOI: https://doi.org/10.1007/s40257-023-00764-w
King B, Shapiro J, Ohyama M, Egeberg A, Piraccini BM, Craiglow B, et al. When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials. Br J Dermatol 2023; 189: 666–673. DOI: https://doi.org/10.1093/bjd/ljad253
Senna M, Mostaghimi A, Ohyama M, Sinclair R, Dutronc Y, Wu WS, et al. Long-term efficacy and safety of baricitinib in patients with severe alopecia areata: 104-week results from BRAVE-AA1 and BRAVE-AA2. J Eur Acad Dermatol Venereol 2024; 38: 583–593. DOI: https://doi.org/10.1111/jdv.19665
Majewski M, Gardaś K, Waśkiel-Burnat A, Ordak M, Rudnicka L. The role of minoxidil in treatment of alopecia areata: a systematic review and meta-analysis. J Clin Med 2024;13: 7712. DOI: https://doi.org/10.3390/jcm13247712
Rudnicka L, Arenbergerova M, Grimalt R, Ioannides D, Katoulis AC, Lazaridou E, et al. European expert consensus statement on the systemic treatment of alopecia areata. J Eur Acad Dermatol Venereol 2024; 38: 687–694. DOI: https://doi.org/10.1111/jdv.19768
Valido K, Kalil L, Peterson D, King B. Combination oral minoxidil and baricitinib treatment of alopecia areata. J Am Acad Dermatol 2025; May 16 [Online ahead of print]. DOI: https://doi.org/10.1016/j.jaad.2025.05.1393
Thompson JM, Mirza MA, Park MK, Qureshi AA, Cho E. The role of micronutrients in alopecia areata: a review. Am J Clin Dermatol 2017; 18: 663–679. DOI: https://doi.org/10.1007/s40257-017-0285-x
Kazmi A, Moussa A, Bokhari L, Bhoyrul B, Joseph S, Chitreddy V, et al. Switching between tofacitinib and baricitinib in alopecia areata: a review of clinical response. J Am Acad Dermatol 2023; 89: 1248–1250. DOI: https://doi.org/10.1016/j.jaad.2023.03.041
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 S. Morteza Seyed Jafari, Pierre A. de Viragh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
